Call Our HELPLINE: 1-800-4PD-INFO (473-4636)

Advocates Guide $16 Million in US Department of Defense Parkinson’s Research Funding for Second Straight Year

Recently, four Parkinson’s Foundation Research Advocates helped guide $16 million in government funding for Parkinson’s disease (PD) research. This is the second straight year in which our Research Advocates have served as consumer reviewers for research funded by the US Department of Defense (DoD). The group included:

  • Bel Broadley, M.B.A., of Downingtown, PA, a US Air Force Veteran, Research Advocate
  • Jay Phillips of Summerville, SC, a US Army Veteran, Research Advocate and member, People with Parkinson’s Advisory Council
  • A.C. Woolnough, M.A., Sandpoint, ID, Research Advocate, Vice Chair, People with Parkinson’s Advisory Council
  • Paul Zimmet, D.D.S., of Reston, VA, a US Army Veteran, Research Advocate

The group of four reviewed applications from scientists seeking funding through the DoD Parkinson’s Research Program. Working alongside scientists, they shared their insights as to how funds could be best spent to improve the lives of people with Parkinson’s.

“As a person with Parkinson’s, I consider our work with DoD to be an honor and a responsibility,” said Mr. Woolnough. “The great news is that our feedback about the needs of the Parkinson’s community was heard by scientists at the highest levels. I am hopeful that partnerships like these will drive improvements in our daily lives.”

“As a leader in patient-driven research, the Parkinson’s Foundation has learned that our community can point us toward the most pressing areas of need in research,” said Veronica Todaro, M.P.H., Vice President, National Programs, Parkinson’s Disease Foundation, a division of the Parkinson’s Foundation. “We applaud DoD for continuing to engage patient advocates to ensure their research funding aligns with community needs.”

Tuesday, March 7, 2017
Parkinson's Foundation Study Finds Gender Disparities in Caregiving, with Women at a Disadvantage
Monday, December 4, 2017

Largest Clinical Study Tracking Parkinson’s Patients Over Time Shows Women with Parkinson’s Have Fewer Caregiving Resources than Men with Parkinson’s

Parkinson’s Foundation Invests $60,000 to Develop Innovative Models of Patient Engagement
Wednesday, November 29, 2017

Six Awards Foster Patient-Driven Parkinson’s Research

Jesse Jackson Diagnosed with Parkinson's Disease
Friday, November 17, 2017

Rev. Jesse Jackson’s announcement today that he has been living with Parkinson’s Disease since 2015 further proves that receiving a diagnosis of Parkinson's is not a death sentence. There are many ways that people living with Parkinson's can control the symptoms of the disease with exercise and physical therapy to help maintain mobility and balance.

Update on Tozadenant Trial for Parkinson’s
Thursday, November 16, 2017

On 11/20/17, Acorda Therapeutics, Inc. announced that it is discontinuing the tozadenant clinical trial.  They concluded that they could not be confident that weekly white blood cell count screening would sufficiently ensure patient safety.

Parkinson’s Foundation Adds Marcia Mondavi Borger to Board of Directors
Tuesday, November 14, 2017

NEW YORK & MIAMI — The Parkinson’s Foundation today announced the election of Marcia Mondavi Borger to its Board of Directors.

Parkinson’s Foundation and Melvin Yahr International Parkinson’s Disease Foundation Announce Merger
Thursday, October 26, 2017

Parkinson’s Foundation Establishes ‘Dr. Melvin Yahr Research Award’ to Fund Neurology Fellows, Promote Leadership Diversity in Parkinson’s Research

Parkinson’s Foundation Welcomes Two New Board Members
Tuesday, October 24, 2017

Peter Goldman and Joshua Raskin Join Board of Directors

NEW YORK & MIAMI — The Parkinson’s Foundation today announced the election of Chicago entrepreneur Peter Goldman and New York financial analyst Joshua Raskin to its Board of Directors.

Parkinson's Foundation Unveils New Brand and Website
Thursday, October 19, 2017

NEW YORK and MIAMI /PRNewswire-USNewswire/ — The Parkinson's Foundation today announced the launch of its new brand and website following the recent merger of two legacy organizations – National Parkinson Foundation and Parkinson's Disease Foundation – as part of its mission to

FDA Approves Extended-Release Amantadine (GOCOVRI™) for Treatment of Dyskinesia
Friday, August 25, 2017

Statement from the Parkinson's Foundation Medical Director, Michael Okun, MD

Parkinson’s Foundation Announces $1.2 Million Investment to Advance Careers, Support Innovation of Early Career Parkinson’s Scientists
Tuesday, August 8, 2017

NEW YORK & MIAMI The Parkinson's Foundation is pleased to announce a $1.2 million investment in 27 career development and fellowship grants to support the work of promising early career scientists in the field of Parkinson's.

Pages

mail icon

Subscribe to get the latest news on treatments, research and other updates.